新聞/Reuters/Cambium Bio Clears US FDA Regulatory Hurdles To Commence Phase 3 Dosing For Elate OcularCambium Bio Clears US FDA Regulatory Hurdles To Commence Phase 3 Dosing For Elate OcularRefinitiv閱讀少於1分鐘CMBCambium Bio Ltd CMB:CLEARS US FDA REGULATORY HURDLES TO COMMENCE PHASE 3 DOSING FOR ELATE OCULARReuters大洋洲澳洲股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html顯示更多登入或建立一個永久免費帳戶來閱讀此新聞讓我們開始吧
